Cardiac Hypertrophy After Transplantation Is Associated With Persistent Expression of Tumor Necrosis Factor-a

Hypervolemia and high tumor necrosis factor-?: An interesting finding during the first six months' posttransplant period in kidney transplant recipients with good renal function

Paydas S.
Karaer R.
Centiner S.

January 2018

PubMedID: 30152426Renal transplantation is the treatment of choice for the end-stage renal disease. ...

Progressive Left Ventricular Hypertrophy after Heart Transplantation: Insights and Mechanisms Suggested by Multimodal Images

Ananthasubramaniam, Karthikeyan
Garikapati, Kiran
Williams, Celeste

February 2016

Immunosuppression is the typical measure to prevent rejection after heart transplantation. Although ...

Hypervolemia and High Tumor Necrosis Factor-alpha: An Interesting Finding During the First Six months' Posttransplant Period in Kidney Transplant Recipients with Good Renal Function

Paydas, Saime
Karaer, Refika
Centiner, Salih

January 2018

WOS: 000443186100017PubMed ID: 30152426Renal transplantation is the treatment of choice for the end-...

Tumor Necrosis Factor-a Is Expressed in Donor Heart and Predicts Right Ventricular Failure After Human

Asghar Khaghani
Julia M. Polak
Magdi H. Yacoub
Emma J. Birks
Virginia J. Owen
Paul B. J. Burton
Anne E. Bishop
Nicholas R. Banner
Failure After
Human Heart Transplantation
Heart Transplantation
Nicholas R. Banner
Frcp Asghar Khaghani
Frcs Julia
M. Polak
Dsc Magdi
H. Yacoub

December 2014

The online version of this article, along with updated information and services, is located on th

Tumor necrosis factor-? is expressed in donor heart and predicts right ventricular failure after human heart transplantation

Birks, Emma J.
Owen, Virginia
Burton, Paul B.J.
Bishop, Anne E.
Banner, Nicholas R.
Khaghani, Asghar
Polak, Julia M.
Yacoub, Magdi H.

July 2000

Background—Myocardial failure is an important problem after heart transplantation. Right ventricular...

Differential intragraft cytokine messenger RNA profiles during rejection and repair of clinical heart transplants. A longitudinal study

de Groot-Kruseman, Hester A
Mol, Wendy M
Niesters, Hubert G M
Maat, Alex P W
van Gelder, Teun
Balk, Aggie H M M
Weimar, Willem
Baan, Carla C

January 2003

After clinical heart transplantation, ischemia, acute rejection, and repair mechanisms can trigger t...

Elevated Levels of Plasma C-Reactive Protein Are Associated With Decreased Graft Survival in Cardiac

Allan Schwartz
Leroy E. Rabbani
Marc S. Eisenberg
Hong Jun Chen
Mark K. Warshofsky
Robert R. Sciacca
Hal S

January 2015

The online version of this article, along with updated information and services, is located on th

Is Related to Cardiac Hypertrophy and

January 2015

The online version of this article, along with updated information and services, is located on th

Tumor Necrosis Factor- and Mortality in Heart Failure A Community Study

Shannon M. Dunlay
Susan A. Weston
Margaret M. Redfield
Jill M. Killian
Véronique L
Shannon M. Dunlay
Md Susan
A. Weston
Ms Margaret
M. Redfield
Jill M. Killian
Bs Véronique
L. Roger

February 2015

The online version of this article, along with updated information and services, is located on th

Before Transplantation Accelerates Cardiac Allograft Rejection, Vascular Inflammation, and Graft Loss

Mandeep R. Mehra
Ashwani K. Khanna
Jianping Xu
Patricia A. Uber
Allen P. Burke
Claudia Baquet
Ashwani K. Khanna
Phd Jianping Xu
Phd Patricia
A. Uber
Pharm D Allen P. Burke
Claudia Baquet
Mph M
Eep R. Mehra

December 2014

The online version of this article, along with updated information and services, is located on th

The TNF-alpha system in heart failure and after heart transplantation: plasma protein levels, mRNA expression, soluble receptors and plasma buffer capacity

Riemsdijk-van Overbeeke, Iza
Baan, Carla
Niesters, Bert
Hesse, Cees
Loonen, E.H.M.
Weimar, Willem
Balk, Aggie
Maat, Alex

January 1999

BACKGROUND: The two soluble tumour necrosis factor (TNF) receptors (sTNF-R1, sTNF-R2) can ...

Plasma tumour necrosis factor correlates with mRNA expression of tumour necrosis factor and mitochondrial transcription factors in skeletal muscle in patients with chronic heart failure treated with cardiac resynchronization therapy: potential role in myopathy

Larsen, Alf Inge
Valborgland, Torstein
Ogne, Christer
Lindal, Sigurd
Halvorsen, Bente
Munk, Peter Scott
Kvaløy, Jan Terje
Aukrust, Pål
Yndestad, Arne

January 2019

Chronic heart failure (CHF) is characterized by inflammation and skeletal muscle myopathy, including...

The TNF-alpha system in heart failure and after heart transplantation:plasma protein levels, mRNA expression, soluble receptors and plasma buffer capacity

van Riemsdijk-van Overbeeke, I C
Baan, C C
Niesters, H G
Hesse, C J
Loonen, E H
Balk, A H
Maat, A P
Weimar, W

June 1999

BACKGROUND: The two soluble tumour necrosis factor (TNF) receptors (sTNF-R1, sTNF-R2) can bind TNF-a...

Activation of the Heart by Donor Brain Death Accelerates Acute Rejection After Transplantation

W. Hancock
Nicholas L. Tilney
Markus J. Wilhelm
Johann Pratschke
Francisca Beato
Maarten Taal
Mamoru Kusaka
Markus J. Wilhelm

January 2015

The online version of this article, along with updated information and services, is located on th

Coronary Microvasculopathy After Heart Transplantation A New Marker to Guide Future Trials?

Leslie W. Miller
Leslie W. Miller

December 2014

The online version of this article, along with updated information and services, is located on th

Hypervolemia and high tumor necrosis factor-?: An interesting finding during the first six months' posttransplant period in kidney transplant recipients with good renal function

Paydas S.
Karaer R.
Centiner S.

January 2018

PubMedID: 30152426Renal transplantation is the treatment of choice for the end-stage renal disease. ...

Progressive Left Ventricular Hypertrophy after Heart Transplantation: Insights and Mechanisms Suggested by Multimodal Images

Ananthasubramaniam, Karthikeyan
Garikapati, Kiran
Williams, Celeste

February 2016

Immunosuppression is the typical measure to prevent rejection after heart transplantation. Although ...

Hypervolemia and High Tumor Necrosis Factor-alpha: An Interesting Finding During the First Six months' Posttransplant Period in Kidney Transplant Recipients with Good Renal Function

Paydas, Saime
Karaer, Refika
Centiner, Salih

January 2018

WOS: 000443186100017PubMed ID: 30152426Renal transplantation is the treatment of choice for the end-...

Tumor Necrosis Factor-a Is Expressed in Donor Heart and Predicts Right Ventricular Failure After Human

Asghar Khaghani
Julia M. Polak
Magdi H. Yacoub
Emma J. Birks
Virginia J. Owen
Paul B. J. Burton
Anne E. Bishop
Nicholas R. Banner
Failure After
Human Heart Transplantation
Heart Transplantation
Nicholas R. Banner
Frcp Asghar Khaghani
Frcs Julia
M. Polak
Dsc Magdi
H. Yacoub

December 2014

The online version of this article, along with updated information and services, is located on th

Tumor necrosis factor-? is expressed in donor heart and predicts right ventricular failure after human heart transplantation

Birks, Emma J.
Owen, Virginia
Burton, Paul B.J.
Bishop, Anne E.
Banner, Nicholas R.
Khaghani, Asghar
Polak, Julia M.
Yacoub, Magdi H.

July 2000

Background—Myocardial failure is an important problem after heart transplantation. Right ventricular...

Differential intragraft cytokine messenger RNA profiles during rejection and repair of clinical heart transplants. A longitudinal study

de Groot-Kruseman, Hester A
Mol, Wendy M
Niesters, Hubert G M
Maat, Alex P W
van Gelder, Teun
Balk, Aggie H M M
Weimar, Willem
Baan, Carla C

January 2003

After clinical heart transplantation, ischemia, acute rejection, and repair mechanisms can trigger t...

Elevated Levels of Plasma C-Reactive Protein Are Associated With Decreased Graft Survival in Cardiac

Allan Schwartz
Leroy E. Rabbani
Marc S. Eisenberg
Hong Jun Chen
Mark K. Warshofsky
Robert R. Sciacca
Hal S

January 2015

The online version of this article, along with updated information and services, is located on th

Is Related to Cardiac Hypertrophy and

January 2015

The online version of this article, along with updated information and services, is located on th

Tumor Necrosis Factor- and Mortality in Heart Failure A Community Study

Shannon M. Dunlay
Susan A. Weston
Margaret M. Redfield
Jill M. Killian
Véronique L
Shannon M. Dunlay
Md Susan
A. Weston
Ms Margaret
M. Redfield
Jill M. Killian
Bs Véronique
L. Roger

February 2015

The online version of this article, along with updated information and services, is located on th

Before Transplantation Accelerates Cardiac Allograft Rejection, Vascular Inflammation, and Graft Loss

Mandeep R. Mehra
Ashwani K. Khanna
Jianping Xu
Patricia A. Uber
Allen P. Burke
Claudia Baquet
Ashwani K. Khanna
Phd Jianping Xu
Phd Patricia
A. Uber
Pharm D Allen P. Burke
Claudia Baquet
Mph M
Eep R. Mehra

December 2014

The online version of this article, along with updated information and services, is located on th

The TNF-alpha system in heart failure and after heart transplantation: plasma protein levels, mRNA expression, soluble receptors and plasma buffer capacity

Riemsdijk-van Overbeeke, Iza
Baan, Carla
Niesters, Bert
Hesse, Cees
Loonen, E.H.M.
Weimar, Willem
Balk, Aggie
Maat, Alex

January 1999

BACKGROUND: The two soluble tumour necrosis factor (TNF) receptors (sTNF-R1, sTNF-R2) can ...

Plasma tumour necrosis factor correlates with mRNA expression of tumour necrosis factor and mitochondrial transcription factors in skeletal muscle in patients with chronic heart failure treated with cardiac resynchronization therapy: potential role in myopathy

Larsen, Alf Inge
Valborgland, Torstein
Ogne, Christer
Lindal, Sigurd
Halvorsen, Bente
Munk, Peter Scott
Kvaløy, Jan Terje
Aukrust, Pål
Yndestad, Arne

January 2019

Chronic heart failure (CHF) is characterized by inflammation and skeletal muscle myopathy, including...

The TNF-alpha system in heart failure and after heart transplantation:plasma protein levels, mRNA expression, soluble receptors and plasma buffer capacity

van Riemsdijk-van Overbeeke, I C
Baan, C C
Niesters, H G
Hesse, C J
Loonen, E H
Balk, A H
Maat, A P
Weimar, W

June 1999

BACKGROUND: The two soluble tumour necrosis factor (TNF) receptors (sTNF-R1, sTNF-R2) can bind TNF-a...

Activation of the Heart by Donor Brain Death Accelerates Acute Rejection After Transplantation

W. Hancock
Nicholas L. Tilney
Markus J. Wilhelm
Johann Pratschke
Francisca Beato
Maarten Taal
Mamoru Kusaka
Markus J. Wilhelm

January 2015

The online version of this article, along with updated information and services, is located on th

Coronary Microvasculopathy After Heart Transplantation A New Marker to Guide Future Trials?

Leslie W. Miller
Leslie W. Miller

December 2014

The online version of this article, along with updated information and services, is located on th

Hypervolemia and high tumor necrosis factor-?: An interesting finding during the first six months' posttransplant period in kidney transplant recipients with good renal function

Paydas S.
Karaer R.
Centiner S.

January 2018

PubMedID: 30152426Renal transplantation is the treatment of choice for the end-stage renal disease. ...

Progressive Left Ventricular Hypertrophy after Heart Transplantation: Insights and Mechanisms Suggested by Multimodal Images

Ananthasubramaniam, Karthikeyan
Garikapati, Kiran
Williams, Celeste

February 2016

Immunosuppression is the typical measure to prevent rejection after heart transplantation. Although ...

Hypervolemia and High Tumor Necrosis Factor-alpha: An Interesting Finding During the First Six months' Posttransplant Period in Kidney Transplant Recipients with Good Renal Function

Paydas, Saime
Karaer, Refika
Centiner, Salih

January 2018

WOS: 000443186100017PubMed ID: 30152426Renal transplantation is the treatment of choice for the end-...

Cardiac Hypertrophy After Transplantation Is Associated With Persistent Expression of Tumor Necrosis Factor-a

Abstract

Extracted data

Cardiac Hypertrophy After Transplantation Is Associated With Persistent Expression of Tumor Necrosis Factor-a

Abstract

Extracted data

Related items

Related items